<HashMap><database>biostudies-arrayexpress</database><scores/><additional><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><submitter>KWANWOO LEE</submitter><instrument_platform>Ion Torrent Proton</instrument_platform><study_type>RNA-seq of coding RNA</study_type><organism>Mus musculus</organism><species>Mus musculus</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-15958</full_dataset_link><description>This study aimed to investigate the transcriptomic changes in the mouse brain following oral administration of theogallin. Whole-brain tissues were collected from 13-week-old male mice (C57BL/6J) treated with theogallin or vehicle control. Total RNA was extracted and subjected to RNA sequencing (RNA-seq) to assess differential gene expression associated with theogallin exposure. The dataset provides a foundation for investigating the therapeutic benefits of theogallin in age-associated cognitive disorders. IonXpress_033~036; BC groups, IonXpress_037~040; BT groups</description><repository>biostudies-arrayexpress</repository><sample_protocol>Sample Collection - Whole brain was collected from 13-week-old male mice that were orally administered theogallin for 1 weeks. Brains were rapidly dissected, snap-frozen in liquid nitrogen, and stored at −80°C until RNA extraction.</sample_protocol><sample_protocol>Library Construction - libraries were prepared with Ion AmpliSeq Transcriptome Mouse Gene Expression Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions.</sample_protocol><sample_protocol>Sequencing - libraries were sequenced on the Ion Proton™ system using IonXpress™ Chip Type P1.1.17 (Thermo Fischer Scientific)</sample_protocol><sample_protocol>Nucleic Acid Extraction - Total RNA was extracted from whole brain tissues using TRIzol reagent (Thermo Fisher Scientific) according to the manufacturer’s instructions. RNA concentration and integrity were assessed with a NanoDrop spectrophotometer and Agilent Bioanalyzer.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><pubmed_authors>KWANWOO LEE</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-seq analysis of whole-brain samples from mice orally administered with Theogallin</name><description>This study aimed to investigate the transcriptomic changes in the mouse brain following oral administration of theogallin. Whole-brain tissues were collected from 13-week-old male mice (C57BL/6J) treated with theogallin or vehicle control. Total RNA was extracted and subjected to RNA sequencing (RNA-seq) to assess differential gene expression associated with theogallin exposure. The dataset provides a foundation for investigating the therapeutic benefits of theogallin in age-associated cognitive disorders. IonXpress_033~036; BC groups, IonXpress_037~040; BT groups</description><dates><release>2025-12-22T00:00:00Z</release><modification>2025-12-22T02:01:21.79Z</modification><creation>2025-11-01T18:15:38.106Z</creation></dates><accession>E-MTAB-15958</accession><cross_references><ENA>ERP183507</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003738</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>